AbbVie, Inc. (ABBV) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1149709,
    "name": "AbbVie, Inc.",
    "stock_name": "AbbVie, Inc.",
    "full_name": "AbbVie, Inc.",
    "name_url": "stocks-analysis/abbvie-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "228.71",
    "chg": -1.53,
    "chgp": "-0.66%",
    "dir": -1,
    "prev_price": "230.24",
    "mcapval": "377,733.67",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US00287Y1091",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "7.47 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abbvie-inc-1149709-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is AbbVie, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-abbvie-inc-technically-bullish-or-bearish-3673609",
        "imagepath": "",
        "date": "2025-11-05 11:20:54",
        "description": "As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals across time frames. The Bollinger Bands show a mildly bullish stance on both weekly and monthly charts, and daily moving averages are also mildly bullish. However, the KST is bullish weekly but mildly bearish monthly, and Dow Theory reflects a mildly bearish weekly outlook against a bullish monthly view. \n\nIn terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -5.32% and -7.70% respectively, while it has outperformed the benchmark year-to-date with a return of 21.49% compared to 16.30%. Overall, the current technical stance is mildly bullish, but with some caution due to mixed signals from various indicators...."
      },
      {
        "title": "Is AbbVie, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-abbvie-inc-technically-bullish-or-bearish-3670796",
        "imagepath": "",
        "date": "2025-11-04 11:32:22",
        "description": "As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals. The Bollinger Bands show a mildly bullish stance in both weekly and monthly time frames. Daily moving averages are mildly bullish, supporting a positive short-term outlook. However, the weekly KST is bullish, contrasting with the monthly KST being mildly bearish. Dow Theory reflects a mildly bearish weekly trend but a bullish monthly trend. \n\nIn terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -7.05% and -9.38% compared to the S&P 500's 0.71% and 1.92%, respectively. However, it has outperformed the index year-to-date with a return of 19.28% versus 16.30%. Overall, the current technical stance is mildly bullish, but the mixed indicators suggest caution...."
      },
      {
        "title": "Is AbbVie, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-abbvie-inc-technically-bullish-or-bearish-3666390",
        "imagepath": "",
        "date": "2025-11-03 11:31:38",
        "description": "As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands show a mildly bullish stance in both time frames. However, the KST is bullish weekly but mildly bearish monthly, and the Dow Theory indicates a mildly bearish weekly trend alongside a bullish monthly trend. The moving averages are mildly bullish on the daily chart. \n\nIn terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -4.36% and -10.78% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. However, it has outperformed the benchmark year-to-date with a return of 22.70% versus 16.30%. Overall, the current technical stance is mildly bullish, but the mixed signals suggest caution...."
      },
      {
        "title": "Is AbbVie, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-abbvie-inc-technically-bullish-or-bearish-3664508",
        "imagepath": "",
        "date": "2025-11-02 11:17:09",
        "description": "As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, and the monthly MACD is also bullish, indicating positive momentum. The Bollinger Bands are mildly bullish on both weekly and monthly time frames. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. The Dow Theory presents a mildly bearish stance on the weekly chart but is bullish on the monthly chart, while the OBV indicates mild bearishness weekly and bullishness monthly.\n\nIn terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -4.36% and -10.78%, respectively, compared to the S&P 500's gains of 0.71% and 1.92%. However, it has outperformed the index year-to-date with a return of 22.70% versus 16.30% for the S&P 500. Overall, the current technical stance is mildly bullish, supported b..."
      },
      {
        "title": "AbbVie Stock Soars to New 52-Week High of $244.81",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbvie-stock-soars-to-new-52-week-high-of-24481-3588364",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbbVieInc_priceRelatedfactors_3588364.png",
        "date": "2025-10-02 22:34:02",
        "description": "AbbVie, Inc. has achieved a new 52-week high, reflecting a strong performance with a notable increase over the past year. The company, with a market capitalization of USD 377,734 million, features a P/E ratio of 23.00 and a high dividend yield, despite some concerning financial metrics."
      },
      {
        "title": "AbbVie, Inc. Hits New 52-Week High of $232.35, Showcasing Strong Growth",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbvie-inc-hits-new-52-week-high-of-23235-showcasing-strong-growth-3586029",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbbVieInc_priceRelatedfactors_3586029.png",
        "date": "2025-10-01 16:37:16",
        "description": "AbbVie, Inc. has achieved a new 52-week high, reflecting strong performance with a notable increase over the past year. The company, with a market capitalization of approximately USD 377.73 billion, features a P/E ratio of 23.00 and a substantial dividend yield, despite challenges in return on equity and debt-equity ratio."
      },
      {
        "title": "AbbVie Stock Soars to Day High with Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbvie-stock-soars-to-day-high-with-strong-intraday-performance-3585866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AbbVieInc_priceRelatedfactors_3585866.png",
        "date": "2025-10-01 16:12:03",
        "description": "AbbVie, Inc. has seen a notable increase in its stock performance today, contrasting with the modest rise of the S&P 500. Over the past week and month, AbbVie has outperformed the index significantly. However, concerns remain regarding its high debt burden and weak long-term fundamentals."
      },
      {
        "title": "AbbVie, Inc. Hits New 52-Week High of $225.16, Showcasing Strong Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbvie-inc-hits-new-52-week-high-of-22516-showcasing-strong-performance-3559337",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AbbVieInc_priceRelatedfactors_3559337.png",
        "date": "2025-09-23 15:40:48",
        "description": "AbbVie, Inc. achieved a new 52-week high of USD 225.16 on September 22, 2025, reflecting a strong performance with a 30.58% increase over the past year. The company, with a market cap of approximately USD 377.73 billion, faces challenges with a negative return on equity despite its notable dividend yield."
      },
      {
        "title": "AbbVie Reaches New 52-Week High of $223.49, Reflecting Strong Growth",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbvie-reaches-new-52-week-high-of-22349-reflecting-strong-growth-3552581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AbbVieInc_priceRelatedfactors_3552581.png",
        "date": "2025-09-22 18:14:53",
        "description": "AbbVie, Inc. has achieved a new 52-week high, reflecting strong performance with a notable increase over the past year. The company, with a market capitalization of USD 377.73 billion, features a P/E ratio of 23.00 and a high dividend yield, despite reporting a negative return on equity."
      }
    ],
    "total": 17,
    "sid": "1149709",
    "stock_news_url": "https://www.marketsmojo.com/news/abbvie-inc-1149709"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is AbbVie, Inc. technically bullish or bearish?

2025-11-05 11:20:54

As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals across time frames. The Bollinger Bands show a mildly bullish stance on both weekly and monthly charts, and daily moving averages are also mildly bullish. However, the KST is bullish weekly but mildly bearish monthly, and Dow Theory reflects a mildly bearish weekly outlook against a bullish monthly view. In terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -5.32% and -7.70% respectively, while it has outperformed the benchmark year-to-date with a return of 21.49% compared to 16.30%. Overall, the current technical stance is mildly bullish, but with some caution due to mixed signals from various indicators....

Is AbbVie, Inc. technically bullish or bearish?

2025-11-04 11:32:22

As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is bullish, indicating mixed signals. The Bollinger Bands show a mildly bullish stance in both weekly and monthly time frames. Daily moving averages are mildly bullish, supporting a positive short-term outlook. However, the weekly KST is bullish, contrasting with the monthly KST being mildly bearish. Dow Theory reflects a mildly bearish weekly trend but a bullish monthly trend. In terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -7.05% and -9.38% compared to the S&P 500's 0.71% and 1.92%, respectively. However, it has outperformed the index year-to-date with a return of 19.28% versus 16.30%. Overall, the current technical stance is mildly bullish, but the mixed indicators suggest caution....

Is AbbVie, Inc. technically bullish or bearish?

2025-11-03 11:31:38

As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands show a mildly bullish stance in both time frames. However, the KST is bullish weekly but mildly bearish monthly, and the Dow Theory indicates a mildly bearish weekly trend alongside a bullish monthly trend. The moving averages are mildly bullish on the daily chart. In terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -4.36% and -10.78% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. However, it has outperformed the benchmark year-to-date with a return of 22.70% versus 16.30%. Overall, the current technical stance is mildly bullish, but the mixed signals suggest caution....

Is AbbVie, Inc. technically bullish or bearish?

2025-11-02 11:17:09

As of 31 October 2025, the technical trend for AbbVie, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, and the monthly MACD is also bullish, indicating positive momentum. The Bollinger Bands are mildly bullish on both weekly and monthly time frames. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. The Dow Theory presents a mildly bearish stance on the weekly chart but is bullish on the monthly chart, while the OBV indicates mild bearishness weekly and bullishness monthly. In terms of performance, AbbVie has underperformed the S&P 500 over the past week and month, with returns of -4.36% and -10.78%, respectively, compared to the S&P 500's gains of 0.71% and 1.92%. However, it has outperformed the index year-to-date with a return of 22.70% versus 16.30% for the S&P 500. Overall, the current technical stance is mildly bullish, supported b...

AbbVie Stock Soars to New 52-Week High of $244.81

2025-10-02 22:34:02

AbbVie, Inc. has achieved a new 52-week high, reflecting a strong performance with a notable increase over the past year. The company, with a market capitalization of USD 377,734 million, features a P/E ratio of 23.00 and a high dividend yield, despite some concerning financial metrics.

AbbVie, Inc. Hits New 52-Week High of $232.35, Showcasing Strong Growth

2025-10-01 16:37:16

AbbVie, Inc. has achieved a new 52-week high, reflecting strong performance with a notable increase over the past year. The company, with a market capitalization of approximately USD 377.73 billion, features a P/E ratio of 23.00 and a substantial dividend yield, despite challenges in return on equity and debt-equity ratio.

AbbVie Stock Soars to Day High with Strong Intraday Performance

2025-10-01 16:12:03

AbbVie, Inc. has seen a notable increase in its stock performance today, contrasting with the modest rise of the S&P 500. Over the past week and month, AbbVie has outperformed the index significantly. However, concerns remain regarding its high debt burden and weak long-term fundamentals.

AbbVie, Inc. Hits New 52-Week High of $225.16, Showcasing Strong Performance

2025-09-23 15:40:48

AbbVie, Inc. achieved a new 52-week high of USD 225.16 on September 22, 2025, reflecting a strong performance with a 30.58% increase over the past year. The company, with a market cap of approximately USD 377.73 billion, faces challenges with a negative return on equity despite its notable dividend yield.

AbbVie Reaches New 52-Week High of $223.49, Reflecting Strong Growth

2025-09-22 18:14:53

AbbVie, Inc. has achieved a new 52-week high, reflecting strong performance with a notable increase over the past year. The company, with a market capitalization of USD 377.73 billion, features a P/E ratio of 23.00 and a high dividend yield, despite reporting a negative return on equity.

View All News